Fund raise · Wednesday 28 October 2026
Debut fund for Formation Bio hits $600m
Formation Bio Drug Development Accelerator Fund closed at $600 million in its debut raise. The vehicle, managed by Formation Bio, acquires and develops clinical-stage drug programmes.
Manager
Formation Bio
Fund
Formation Bio Drug Development Accelerator Fund
Amount
$600m
Announced
Wednesday 28 October 2026
More fundraising news · past 20 days
$26bn committed toward Brookfield infrastructure fund
Friday 6 November · $26bn · Final close
Proterra closes $680m credit fund
Thursday 5 November · $680m · Final close
Crescendo takes $350m first close toward $1bn target
Thursday 5 November · $350m · First close
Above target close takes Allianz Global's infrastructure debt fund to €1.5bn
Tuesday 3 November · €1.5bn · Final close
Clarion closes €552m sale-leaseback fund
Tuesday 3 November · €552m · Final close
Hard cap of €450m for Intera Partners
Tuesday 3 November · €450m · Hard cap
€6bn, above target, for Igneo's infrastructure fund
Monday 2 November · €6bn · Final close
Churchill tops target with $1.54bn debt fund
Monday 2 November · $1.54bn · Final close
Early-stage fund Creandum VIII closes at $750m
Monday 2 November · $750m · Final close
TPG announces $10.4bn across two climate funds
Thursday 29 October · $10.4bn · Final close
The Fundraising Monitor is a proprietary automated review. It records the fund raises AIP has tracked, not a complete count of the market, and nothing in it is investment advice or a recommendation.
Receive The Alternative Investor each month, with news and features from across private capital.
Subscribe